Cohort characteristics by frequency of multivitamin supplement use in the NIH-AARP Diet and Health Study cohort.

<p>Cohort characteristics by frequency of multivitamin supplement use in the NIH-AARP Diet and Health Study cohort.</p

Adjusted hazard ratios (HR) and 95% confidence intervals (CI) for any use of multivitamin supplements for four upper gastrointestinal cancers stratified by sex or smoking in the NIH-AARP Diet and Health Study cohort.

<p>Of the eight tests, only smoking status for esophageal adenocarcinoma showed significant effect modification (P = 0.022), but the estimates in both strata have confidence intervals that include 1.</p

Crude and adjusted^* hazard ratios (HR) and 95% confidence intervals (CI) for use of multivitamin supplements for four upper gastrointestinal cancers in the NIH-AARP Diet and Health Study cohort.

<p>*Adjustments included age at cohort entry, sex, education, smoking status and intensity, alcohol use, fruit intake, vegetable intake, body mass index (BMI), vigorous physical activity, usual physical activity during the day, and total energy intake. ESCC = esophageal squamous cell carcinoma; EADC = esophageal adenocarcinoma; GCA = gastric cardia adenocarcinoma; GNCA = gastric noncardia adenocarcinoma.</p

Adjusted^* hazard ratios (HR) and 95% confidence intervals (CI) for use of individual vitamin or mineral supplements for four upper gastrointestinal cancers in the NIH-AARP Diet and Health Study cohort.

<p>*Adjustments included age at cohort entry, sex, education, smoking status and intensity, alcohol use, fruit intake, vegetable intake, body mass index (BMI), vigorous physical activity, usual physical activity during the day, and total energy intake.</p><p>**Any use defined as reporting use more than once per month. ESCC = esophageal squamous cell carcinoma; EADC = esophageal adenocarcinoma; GCA = gastric cardia adenocarcinoma; GNCA = gastric noncardia adenocarcinoma.</p

Distributions of 60 esophageal cancer patients ≤30 years of age seen at Tenwek Hospital from January 1996 through June 2009 who had follow-up information.

<p>Distributions of 60 esophageal cancer patients ≤30 years of age seen at Tenwek Hospital from January 1996 through June 2009 who had follow-up information.</p

Summary of age, sex and histologic data from published reports of esophageal cancer in young persons, overall and separately in developing and developed countries.

<p>Summary of age, sex and histologic data from published reports of esophageal cancer in young persons, overall and separately in developing and developed countries.</p

Survival with esophageal cancer in young patients by sex.

<p>Survival by sex of the 60 esophageal cancer patients ≤30 years of age seen at Tenwek Hospital from January 1996 through June 2009 who had follow-up information.</p

Home villages of young esophageal cancer patients.

<p>Locations of the home villages of the 109 esophageal cancer patients ≤30 years of age seen at Tenwek Hospital (star) from January 1996 through June 2009.</p

Distributions of risk factors overall and by sex for esophageal cancer among patients ≤30 years of age seen at Tenwek Hospital from January 1996 through June 2009 who had follow-up information.

<p>Distributions of risk factors overall and by sex for esophageal cancer among patients ≤30 years of age seen at Tenwek Hospital from January 1996 through June 2009 who had follow-up information.</p